BES2021 Belgian Endocrine Society 2021 Abstracts (26 abstracts)
Prevalence of and risk factors for sexual dysfunctions in adults with type 1 or type 2 diabetes: Results from Diabetes MILES - Flanders
Van Cauwenberghe Jolijn 1,2 , Enzlin Paul 3,4 , Nefs Giesje 5,6,7 , Ruige Johannes 1,8 , Hendrieckx Christel 9,10 , De Block Christophe 1,2 & Pouwer Frans 9,11,12
1Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Edegem, Belgium; 2Laboratorium of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; 3Department of Neurosciences, Institute for Family and Sexuality Studies, KU Leuven, Leuven, Belgium; 4Centre for Clinical Sexology and Sex Therapy, UPC KU Leuven, Leuven, Belgium; 5Department of Medical Psychology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands; 6Diabeter, National Treatment and Research Center for Children, Adolescents and Adults With Type1 Diabetes, Rotterdam, the Netherlands; 7Department of Medical and Clinical Psychology, Center of Research on Psychological and Somatic disorders (CoRPS), Tilburg University, Tilburg, the Netherlands; 8Centrum Diabeteszorg, AZ Nikolaas, Sint-Niklaas, Belgium; 9School of Psychology, Deakin University, Geelong, Victoria, Australia; 10The Australian Centre for Behavioural Research in Diabetes, Melbourne, Victoria, Australia; 11Department of Psychology, University of Southern Denmark, Odense, Denmark; 12Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark
Background and aims: The prevalence of sexual dysfunctions in people with diabetes is still debated and understudied in women. This study examines the prevalence of sexual dysfunction in men and women with type 1 or type 2 diabetes (T1D or T2D) and the associations with clinical and psychological variables.
Methods: Adults with diabetes (n756) completed an online survey including questions on sexual functioning (adapted Short Sexual Functional Scale), general emotional well-being (WHO-5), symptoms of anxiety (GAD-7), diabetes distress (PAID-20) and healthcare use.
Results: One third of participants reported a sexual dysfunction. Men reported erectile dysfunction (T1D:20%; T2D: 33%), and orgasmic dysfunction (T1D:22%; T2D:27%). In men, sexual dysfunction was independently associated with, older age (OR=1.05, P = 0.019), higher waist circumference (OR=1.04; P = 0.001) and longer duration of diabetes (OR=1.04; P = 0.007). More men with sexual dysfunction reported diabetes distress (20% vs. 12%, P = 0.026). Women reported decreased desire (T1D:22%; T2D:15%) and decreased arousal (T1D:9%; T2D:11%). More women with sexual dysfunction reported diabetes distress (36% vs. 21%, P = 0.003), impaired emotional well-being (36% vs. 25%, P = 0.036) and anxiety symptoms (20% vs. 11%, P = 0.026).
Conclusion: Sexual dysfunctions are common in diabetes and differ between men and women. In men clinical factors are associated with sexual dysfunction. More women with sexual dysfunction had low well-being and anxiety symptoms compared to women without sexual dysfunction. For both men and women, sexual dysfunction was associated with diabetes distress.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more